CD8A and cancer: CD8+ lymphocytes directly kill the cancer cells, while the CD4+ cells (Th1- and Th2-lymphocytes) provoke the immune response against cancer cells, producing pro-inflammatory cytokines, recruiting other immune cell and interacting with the B cells to induce antibody production.